NCT00003778View on ClinicalTrials.gov

Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

April 30, 1999

Primary Completion Date

July 31, 2000

Conditions
Ovarian CancerSarcoma
Interventions
DRUG

dolastatin 10

Trial Locations (4)

19111

Fox Chase Cancer Center, Philadelphia

43210

Arthur G. James Cancer Hospital - Ohio State University, Columbus

55905

Mayo Clinic Cancer Center, Rochester

80262

University of Colorado Cancer Center, Denver

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH